Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 211

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 211
---
 proprietary trade secrets and know-how, in part, by entering into confidentiality
agreements with consultants, scientific advisors and contractors and invention assignment agreements with our employees. We also seek
to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical
and electronic security of our information technology systems. While we have confidence in these individuals, organizations and systems,
agreements or security measures may be breached, giving our competitors knowledge of our trade secrets and know-how, and we may not have
adequate remedies for any such breach, in which case our business could be adversely affected. Our trade secrets will not prevent our
competitors from independently discovering or developing the same know-how. Although our agreements with our consultants, contractors
or collaborators require them to provide us only original work product and prohibit them from incorporating or using IP owned by others
in their work for us, if they breach these obligations, disputes may arise as to the rights in any know-how or inventions that arise from
their work.

Our commercial success will
also depend in part on not infringing the proprietary rights of other parties. Although we seek to review the patent landscape relevant
to our technologies on an ongoing basis, we may become aware of a new patent which has been issued to others with claims covering or related
to aspects of one of our drug candidate. The issuance of such a patent could require us to alter our development plans for that candidate,
redesign the candidate, obtain a license from the patent holder or cease development. Our inability to obtain a license to proprietary
rights that we may require to develop or commercialize any of our drug candidates would have a material adverse impact on us.

Trademarks

As of the date hereof, we
own trademark registrations covering the trade names and logos of Aptorum and our subsidiaries, including but not limited to “APTORUM”,
“APTORUM THERAPEUTICS,” “VIDENS LIFE SCIENCES,” “ACTICULE LIFE SCIENCES,” “NATIVUS LIFE SCIENCES,” “NativusWell,” “TALEM”
in jurisdictions Hong Kong, EU and the United Kingdom and PRC. Furthermore, we are in the process of applying for registration of trademarks
in jurisdictions including the U.S., EU, the United Kingdom, Australia and PRC.

We also own certain unregistered
trademark rights.

All other trade names, trademarks
and service marks of other companies appearing in this registration statement are the property of their respective holders. Solely for